Finance

Lists
Q1 2027 earnings • released • EPS miss -7.56% • Revenue miss -1.46%
See results
ALKEM:NSE
Alkem Laboratories Ltd
₹5,325.00
-2.28%
(-124.50) 1D
Aug 14, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ALKEM...
Open
₹5,432.00
High
₹5,448.00
Low
₹5,175.00
Mkt. cap
636.68B
Avg. vol.
0.00
Volume
635.60K
Dividend
1.00%
Quarterly dividend
₹13.25
Ex-dividend date
Aug 7, 2026
P/E ratio
27.66
52-wk high
₹5,933.50
52-wk low
₹5,075.00
EPS
₹192.51
Shares outstanding
119.55M
No. of employees
19K
Open
₹5,432.00
High
₹5,448.00
Low
₹5,175.00
Mkt. cap
636.68B
Avg. vol.
0.00
Volume
635.60K
Dividend
1.00%
Quarterly dividend
₹13.25
Ex-dividend date
Aug 7, 2026
P/E ratio
27.66
52-wk high
₹5,933.50
52-wk low
₹5,075.00
EPS
₹192.51
Shares outstanding
119.55M
No. of employees
19K
News stories
From web sources and news partners
Profile
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets. Wikipedia
About Alkem Laboratories Ltd
CEO-
Employees19.3K
Founded1973
HeadquartersMumbai, Maharashtra, India
SectorPharmaceutical industry
Websitealkemlabs.com
Last report
Aug 14, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹43.49 / ₹47.04
-7.56%miss
Revenue / Est. (INR)
37.40B / 37.96B
-1.46%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
40.01B
37.37B
36.03B
37.40B
Cost of goods sold
14.01B
12.73B
14.33B
12.01B
Cost of revenue
14.01B
12.73B
14.33B
12.01B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.10B
7.22B
17.12B
8.09B
Operating expense
17.73B
17.31B
17.80B
18.73B
Total operating expenses
31.74B
30.04B
32.13B
30.74B
Operating income
8.27B
7.33B
3.90B
6.66B
Other non operating income
1.04B
1.43B
-3.55B
1.53B
EBT including unusual items
8.95B
7.81B
4.22B
7.71B
EBT excluding unusual items
8.95B
8.33B
4.77B
7.71B
Income tax expense
1.16B
1.28B
1.71B
2.50B
Effective tax rate
12.98%
16.35%
40.53%
32.47%
Other operating expenses
9.69B
9.15B
-378.70M
9.64B
Net income
7.65B
6.36B
2.36B
5.20B
Net profit margin
19.12%
17.02%
6.56%
13.90%
Earnings per share
63.99
56.88
26.50
43.49
Interest and investment income
-
-
3.92B
-
Interest expense
-350.20M
-421.00M
-336.50M
-466.20M
Net interest expenses
-350.20M
-421.00M
3.58B
-466.20M
Depreciation and amortization charges
936.10M
950.10M
1.06B
1.00B
EBITDA
9.18B
8.11B
4.67B
7.43B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps